Abstract

Detailed hematologic and globin chain synthesis studies were performed in a special group of six patients with thalassemia syndrome who were offsprings of segregation of classical β-thalassemia trait (increased HbA2 and normal or slightly elevated HbF), to "silent" β-thalassemia trait (normal HbA2 and HbF, but impaired β-chain synthesis). Clinically these patients varied widely, from those severely affected which necessitated regular transfusions since the first year of life, to others with an intermediate clinical course without transfusion requirements. The levels of both HbA (28-80%), and HbF (18-70%), varied widely. Of interest were the results of globin chain synthesis in the patients with the "silent" β-thalassemia gene and their siblings; the ratio of a to non-a chains ranged from 1.43 to 3.02 indicating a considerable variation in the degree of impairement of β-chain synthesis. This favors the assumption that a heterogeneity in "silent" β-thalassemia gene may exists, and that the extreme variation in the clinical severity observed in double heterozygotes patients, could be associated with heterogeneity of the "silent" thalassemia gene.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.